Hirota J, Furuichi T, Mikoshiba K
Mikoshiba Calciosignal Net Project, Exploratory Research for Advanced Technology, Japan Science and Technology Corporation, 2-28-8 Honkomagome, Bunkyo-ku, Tokyo 113-0021, Japan.
J Biol Chem. 1999 Nov 26;274(48):34433-7. doi: 10.1074/jbc.274.48.34433.
The inositol 1,4,5-trisphosphate (IP(3)) receptor (IP(3)R), an IP(3)-gated Ca(2+) channel located on intracellular Ca(2+) stores, modulates intracellular Ca(2+) signaling. During apoptosis of the human T-cell line, Jurkat cells, as induced by staurosporine or Fas ligation, IP(3)R type 1 (IP(3)R1) was found to be cleaved. IP(3)R1 degradation during apoptosis was inhibited by pretreatment of Jurkat cells with the caspase-3 (-like protease) inhibitor, Ac-DEVD-CHO, and the caspases inhibitor, z-VAD-CH(2)DCB but not by the caspase-1 (-like protease) inhibitor, Ac-YVAD-CHO, suggesting that IP(3)R1 was cleaved by a caspase-3 (-like) protease. The recombinant caspase-3 cleaved IP(3)R1 in vitro to produce a fragmentation pattern consistent with that seen in Jurkat cells undergoing apoptosis. N-terminal amino acid sequencing revealed that the major cleavage site is (1888)DEVD*(1892)R (mouse IP(3)R1), which involves consensus sequence for caspase-3 cleavage (DEVD). To determine whether IP(3)R1 is cleaved by caspase-3 or is proteolyzed in its absence by other caspases, we examined the cleavage of IP(3)R1 during apoptosis in the MCF-7 breast carcinoma cell line, which has genetically lost caspase-3. Tumor necrosis factor-alpha- or staurosporine-induced apoptosis in caspase-3-deficient MCF-7 cells failed to demonstrate cleavage of IP(3)R1. In contrast, MCF-7/Casp-3 cells stably expressing caspase-3 showed IP(3)R1 degradation upon apoptotic stimuli. Therefore IP(3)R1 is a newly identified caspase-3 substrate, and caspase-3 is essential for the cleavage of IP(3)R1 during apoptosis. This cleavage resulted in a decrease in the channel activity as IP(3)R1 was digested, indicating that caspase-3 inactivates IP(3)R1 channel functions.
肌醇1,4,5 -三磷酸(IP(3))受体(IP(3)R)是一种位于细胞内钙库上的IP(3)门控钙通道,可调节细胞内钙信号传导。在由星形孢菌素或Fas配体诱导的人T细胞系Jurkat细胞凋亡过程中,发现1型IP(3)受体(IP(3)R1)被切割。用半胱天冬酶-3(类半胱天冬酶蛋白酶)抑制剂Ac-DEVD-CHO和半胱天冬酶抑制剂z-VAD-CH(2)DCB预处理Jurkat细胞可抑制凋亡过程中IP(3)R1的降解,但半胱天冬酶-1(类半胱天冬酶蛋白酶)抑制剂Ac-YVAD-CHO则不能,这表明IP(3)R1是被一种半胱天冬酶-3(类)蛋白酶切割的。重组半胱天冬酶-3在体外切割IP(3)R1,产生的片段化模式与凋亡的Jurkat细胞中观察到的一致。N端氨基酸测序显示主要切割位点为(1888)DEVD*(1892)R(小鼠IP(3)R1),这涉及半胱天冬酶-3切割的共有序列(DEVD)。为了确定IP(3)R1是被半胱天冬酶-3切割还是在其缺失时被其他半胱天冬酶蛋白水解,我们检测了在基因上缺失半胱天冬酶-3的MCF-7乳腺癌细胞系凋亡过程中IP(3)R1的切割情况。肿瘤坏死因子-α或星形孢菌素诱导半胱天冬酶-3缺陷型MCF-7细胞凋亡时,未显示出IP(3)R1的切割。相反,稳定表达半胱天冬酶-3的MCF-7/Casp-3细胞在凋亡刺激后显示出IP(3)R1降解。因此,IP(3)R1是一种新鉴定的半胱天冬酶-3底物,并且半胱天冬酶-3对于凋亡过程中IP(3)R1的切割至关重要。随着IP(3)R1被消化,这种切割导致通道活性降低,表明半胱天冬酶-3使IP(3)R1通道功能失活。